Panagiotis V.

Panagiotis V. is a seasoned finance professional with extensive experience in the biotechnology, pharmaceutical, and medical device sectors. Currently serving as a Business Angel Investor at Go Beyond Investing since June 2016, Panagiotis has held key leadership positions such as VP, Head of Finance EMEA at argenx from 2021 to 2025, and VP, Head of Finance for EMEA Gene Therapy at AveXis, Inc. from 2018 to 2021. Prior roles include Director of Finance at QGel and Global Finance Director for Metabolic Disorder at Alexion Pharmaceuticals, where significant contributions included strategic operational planning and pricing strategy for ultra-orphan drugs. Panagiotis has also managed finance operations across Central Eastern Europe and the Middle East, establishing multiple legal entities and ensuring compliance with SOX regulations. Educational credentials include advanced studies in Biotech-Medtech from EPFL, an executive course at Harvard Business School, as well as a B.A. in Economics from the University of Sunderland.